Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lee Helman

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Cancer Journal (Sudbury, Mass.)|June 10, 2008
Phase 0 clinical trials: conceptions and misconceptionsShivaani Kummar, Larry Rubinstein, Robert Kinders, et al.
Molecular Interventions|January 18, 2008
Phase 0 clinical trials in cancer drug development: from FDA guidance to clinical practiceRobert Kinders, Ralph E Parchment, Jay Ji, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
Testing of new agents in childhood cancer preclinical models: meeting summaryPeter J Houghton, Peter C Adamson, Susan Blaney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 15, 2009
Phase 0 clinical trial of the poly (ADP-ribose) polymerase inhibitor ABT-888 in patients with advanced malignanciesShivaani Kummar, Robert Kinders, Martin E Gutierrez, et al.
Sarcoma|May 14, 2020
Results of a Randomized, Double-Blinded, Placebo-Controlled, Phase 2.5 Study of Saracatinib (AZD0530), in Patients with Recurrent Osteosarcoma Localized to the LungKristin Baird, John Glod, Seth M Steinberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 22, 2010
Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutationsKatherine A Janeway, Su Young Kim, Maya Lodish, et al.
Cancer Discovery|April 4, 2013
Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumorJ Keith Killian, Su Young Kim, Markku Miettinen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2003
Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summaryRichard Gorlick, Peter Anderson, Irene Andrulis, et al.
Oncotarget|January 24, 2016
The second European interdisciplinary Ewing sarcoma research summit--A joint effort to deconstructing the multiple layers of a complex diseaseHeinrich Kovar, James Amatruda, Erika Brunet, et al.
Nature Genetics|June 4, 2013
Genome-wide association study identifies two susceptibility loci for osteosarcomaSharon A Savage, Lisa Mirabello, Zhaoming Wang, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Cancer Journal (Sudbury, Mass.)|June 10, 2008
Phase 0 clinical trials: conceptions and misconceptionsShivaani Kummar, Larry Rubinstein, Robert Kinders, et al.
Molecular Interventions|January 18, 2008
Phase 0 clinical trials in cancer drug development: from FDA guidance to clinical practiceRobert Kinders, Ralph E Parchment, Jay Ji, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
Testing of new agents in childhood cancer preclinical models: meeting summaryPeter J Houghton, Peter C Adamson, Susan Blaney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 15, 2009
Phase 0 clinical trial of the poly (ADP-ribose) polymerase inhibitor ABT-888 in patients with advanced malignanciesShivaani Kummar, Robert Kinders, Martin E Gutierrez, et al.
Sarcoma|May 14, 2020
Results of a Randomized, Double-Blinded, Placebo-Controlled, Phase 2.5 Study of Saracatinib (AZD0530), in Patients with Recurrent Osteosarcoma Localized to the LungKristin Baird, John Glod, Seth M Steinberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 22, 2010
Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutationsKatherine A Janeway, Su Young Kim, Maya Lodish, et al.
Cancer Discovery|April 4, 2013
Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumorJ Keith Killian, Su Young Kim, Markku Miettinen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2003
Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summaryRichard Gorlick, Peter Anderson, Irene Andrulis, et al.
Oncotarget|January 24, 2016
The second European interdisciplinary Ewing sarcoma research summit--A joint effort to deconstructing the multiple layers of a complex diseaseHeinrich Kovar, James Amatruda, Erika Brunet, et al.
Nature Genetics|June 4, 2013
Genome-wide association study identifies two susceptibility loci for osteosarcomaSharon A Savage, Lisa Mirabello, Zhaoming Wang, et al.
Pageof 4